– Paxos has raised $300m funding.
– The round was led by Oak HC/FT and joined by Declaration Partners, PayPal Ventures, Mithril Capital, Senator Investment Group, Liberty City Ventures and WestCap.
– Paxos offers different products, such as crypto trading and settlement, custody and the ability to issue tokens.
– It focuses on big enterprise clients, such as Revolut, Crédit Suisse, Société Générale and StoneX.
– The company tries to be as compliant as possible. And it plans to remain committed to regulation across several geographies and verticals.

– Adagio Therapeutics, Inc., a biotechnology company developing best-in-class antibodies to broadly neutralize coronaviruses, today announced the completion of a $336m Series C financing led by RA Capital Management, with participation from new investors, including Redmile Group, Federated Hermes, Foresite Capital, ArrowMark Partners, PremjiInvest, and another leading healthcare investor.
– Existing investors Fidelity Management & Research Company, LLC, OrbiMed, Polaris Partners, Mithril, GV, Population Health Partners, Adimab and Omega Funds also participated in the financing.

– Flex Logix raised a $55M Series D financing round.
– The round was led by Mithril Capital Management with participation from existing investors Lux Capital, Eclipse Ventures, and the Tate Family Trust.
– Flex Logix’s inference architecture is unique. It is optimized for low latency operation required by edge megapixel vision applications.
– It combines numerous 1-dimensional tensor processors with reconfigurable, high bandwidth, non-blocking interconnect that enables each layer of the neural network model to be configured for maximum utilization, resulting in very high performance with less cost and power.
– The connections between compute and memory are reconfigured in millionths of a second as the model is processed.

– ForSight Robotics is developing a surgical robotic platform that will transform the future of ophthalmic surgery with a $10m seed round led by Eclipse Ventures and joined by Mithril Capital.
– The mission is to re-imagine ophthalmic surgery by applying the most advanced technologies in microsurgical robotics, computer visualization and machine learning.
– The platform will automate the complex subtleties of ophthalmic surgery with an intuitive, patient-centric system that tackles the profound and growing problems of preventable blindness and visual impairment.
– Many of the leading causes of blindness worldwide can be prevented with timely surgical procedures. However, ophthalmic microsurgery is intricate and challenging, requiring many years to master. Also, trained ophthalmic surgeons are in extremely short supply worldwide.